| Month | Distributions | No. of shares | Net Distribution / share |
|---|---|---|---|
| August 2024 | $57.75 | 124 | $0.4657 |
| July 2024 | $60.72 | 124 | $0.4897 |
| June 2024 | $104.74 | 124 | $0.8447 |
| May 2024 | $117.45 | 124 | $0.9472 |
| April 2024 | $97.12 | 124 | $0.7832 |
| March 2024 | $49.76 | 44 | $1.1309 |
| February 2024 | $26.15 | 44 | $0.5943 |
| Grand Total: | $853.79 | 2,196 | $0.3888 |
| Investment | Shares | Distributions | Purchase price / share | Real price / share | Market price / share |
|---|---|---|---|---|---|
| $2,630.64 | 124 | $853.79 | $21.21 | $14.33 | $1.71 |
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an actively managed ETF launched on October 24, 2023, designed to generate monthly income through a synthetic covered call strategy. It provides indirect exposure to Moderna, Inc. (MRNA) stock, using options contracts to collect premiums while capping potential gains. Distributions are paid monthly, with a high yield (e.g., 157.72% as of August 2025), though subject to market volatility and risks.
Invest wisely. Past performance is not indicative of future results.